TY - JOUR
T1 - Risk of Cognitive Impairment in Patients With Parkinson's Disease With Visual Hallucinations and Subjective Cognitive Complaints
AU - Santos García, Diego
AU - de Deus Fonticoba, Teresa
AU - Bartolomé, Carlos C.
AU - Feal Painceiras, Maria J.
AU - Paz González, Jose M.
AU - Martinez Miró, Cristina
AU - Jesús, Silvia
AU - Aguilar, Miguel
AU - Pastor, Pau
AU - Planellas, Lluis
AU - Cosgaya, Marina
AU - Garcia Caldentey, Juan
AU - Caballol, Nuria
AU - Legarda, Ines
AU - Hernandez Vara, Jorge
AU - Cabo-Lopez, Iria
AU - Lopez Manzanares, Lydia
AU - Gonzalez Aramburu, Isabel
AU - Ávila Rivera, Maria A.
AU - Gomez Mayordomo, Victor
AU - Nogueira, Victor
AU - Puente, Victor
AU - Dotor García-Soto, Julio
AU - Borrué, Carmen
AU - Solano Vila, Berta
AU - Álvarez Sauco, Maria
AU - Vela, Lydia
AU - Escalante, Sonia
AU - Cubo, Esther
AU - Carrillo Padilla, Francisco
AU - Martinez Castrillo, Juan C.
AU - Sanchez Alonso, Pilar
AU - Alonso Losada, M.G.
AU - Lopez Ariztegui, Nuria
AU - Gastón, Itziar
AU - Kulisevsky, Jaime
AU - Blázquez Estrada, Marta
AU - Seijo, Manuel
AU - Ruiz Martínez, Javier
AU - Valero, Caridad
AU - Kurtis, Monica
AU - de Fábregues, Oriol
AU - Gonzalez Ardura, Jessica
AU - Alonso Redondo, Ruben
AU - Ordás, Carlos
AU - Lopez Diaz L., Luis M.
AU - McAfee, Darrian
AU - Martinez-Martin, Pablo
AU - Mir, Pablo
AU - Coppadis Study Group, None
PY - 2023
Y1 - 2023
N2 - Visual hallucinations (VH) and subjective cognitive complaints (SCC) are associated with cognitive impairment (CI) in Parkinson's disease. Our aims were to determine the association between VH and SCC and the risk of CI development in a cohort of patients with Parkinson's disease and normal cognition (PD-NC). Methods Patients with PD-NC (total score of >80 on the Parkinson's Disease Cognitive Rating Scale [PD-CRS]) recruited from the Spanish COPPADIS cohort from January 2016 to November 2017 were followed up after 2 years. Subjects with a score of ≥1 on domain 5 and item 13 of the Non-Motor Symptoms Scale at baseline (V0) were considered as "with SCC" and "with VH," respectively. CI at the 2-year follow-up (plus or minus 1 month) (V2) was defined as a PD-CRS total score of <81. At V0 (n=376, 58.2% males, age 61.14±8.73 years [mean±SD]), the frequencies of VH and SCC were 13.6% and 62.2%, respectively. VH were more frequent in patients with SCC than in those without: 18.8% (44/234) vs 4.9% (7/142), p<0.0001. At V2, 15.2% (57/376) of the patients had developed CI. VH presenting at V0 was associated with a higher risk of CI at V2 (odds ratio [OR]=2.68, 95% confidence interval=1.05-6.83, p=0.039) after controlling for the effects of age, disease duration, education, medication, motor and nonmotor status, mood, and PD-CRS total score at V0. Although SCC were not associated with CI at V2, presenting both VH and SCC at V0 increased the probability of having CI at V2 (OR=3.71, 95% confidence interval= 1.36-10.17, p=0.011). VH were associated with the development of SCC and CI at the 2-year follow-up in patients with PD-NC.
AB - Visual hallucinations (VH) and subjective cognitive complaints (SCC) are associated with cognitive impairment (CI) in Parkinson's disease. Our aims were to determine the association between VH and SCC and the risk of CI development in a cohort of patients with Parkinson's disease and normal cognition (PD-NC). Methods Patients with PD-NC (total score of >80 on the Parkinson's Disease Cognitive Rating Scale [PD-CRS]) recruited from the Spanish COPPADIS cohort from January 2016 to November 2017 were followed up after 2 years. Subjects with a score of ≥1 on domain 5 and item 13 of the Non-Motor Symptoms Scale at baseline (V0) were considered as "with SCC" and "with VH," respectively. CI at the 2-year follow-up (plus or minus 1 month) (V2) was defined as a PD-CRS total score of <81. At V0 (n=376, 58.2% males, age 61.14±8.73 years [mean±SD]), the frequencies of VH and SCC were 13.6% and 62.2%, respectively. VH were more frequent in patients with SCC than in those without: 18.8% (44/234) vs 4.9% (7/142), p<0.0001. At V2, 15.2% (57/376) of the patients had developed CI. VH presenting at V0 was associated with a higher risk of CI at V2 (odds ratio [OR]=2.68, 95% confidence interval=1.05-6.83, p=0.039) after controlling for the effects of age, disease duration, education, medication, motor and nonmotor status, mood, and PD-CRS total score at V0. Although SCC were not associated with CI at V2, presenting both VH and SCC at V0 increased the probability of having CI at V2 (OR=3.71, 95% confidence interval= 1.36-10.17, p=0.011). VH were associated with the development of SCC and CI at the 2-year follow-up in patients with PD-NC.
KW - Cognitive impairment
KW - Dementia
KW - Parkinson's disease
KW - Subjective cognitive complaints
KW - Visual hallucinations
U2 - 10.3988/jcn.2022.0186
DO - 10.3988/jcn.2022.0186
M3 - Article
C2 - 36647231
SN - 1738-6586
VL - 19
SP - 344
EP - 357
JO - Journal of Clinical Neurology (Korea)
JF - Journal of Clinical Neurology (Korea)
IS - 4
ER -